| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Aurinia Pharmaceuticals Inc.
13D/A
Amendment 17
AUPH · 05156V102
|
4.4% |
8/26/2026
Event 8/20/2026
|
|||
| ILJIN SNT Co., Ltd. | 3.7% | ||||
| ILJIN Steel Co., Ltd. | 0.7% | ||||
| ILJIN GLS Co., Ltd. | 3.7% | ||||
| Sae Kyoung Huh | 0.4% | ||||
| Seoung Eun Huh | 0.1% | ||||
| Chin Kyu Huh | 4.4% | ||||
|
Aurinia Pharmaceuticals Inc.
13D/A
Amendment 16
AUPH · 05156V102
|
5.0% |
8/13/2025
Event 8/11/2025
|
|||
| ILJIN SNT Co., Ltd. | 4.1% | ||||
| ILJIN Steel Co., Ltd. | 0.9% | ||||
| ILJIN GLS Co., Ltd. | 4.1% | ||||
| Sae Kyoung Huh | 0.4% | ||||
| Seoung Eun Huh | 0.3% | ||||
| Chin Kyu Huh | 5.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.